The ATTAIN Study: A Therapeutic Trial of Afatinib In the Neoadjuvant Setting
Status:
Terminated
Trial end date:
2017-08-16
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if it is tolerable for patients with
NSCLC to receive afatinib before surgery. The safety of this drug will also be studied.